http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103408636-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8976e63ccfa14d6ed9b09ba7c17b6c33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_883ef14066c153ff611ef557b6c22f71
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-078
filingDate 2013-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a79300f1f08a1a8e00beb577726bae7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4190aec13b0f4782a6eb1532ddee3c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f66acb5706245d8aa03c2b2cada6c4be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9021f57ce13c6f6acaf8df47a2ad479a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b84ebc81b413ab14a9aa2db57d553d84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75f78a9ddab3885c233773e225584731
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c0e9e21a76edec50a168faab6c1462f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff7060c60672cc399dca1b398a15c694
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e520e25c471c3cce10c4af1f6ddf200
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ded1914333bc3131f2fe562f5785db1
publicationDate 2015-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103408636-B
titleOfInvention Synthetic method of 26S protease inhibitors
abstract The invention relates to a preparation method of bortezomib. The preparation method of bortezomib comprises the following steps of: (1) carrying out a condensation reaction on L-phenylalanine and pyrazine-2-formic acid to obtain N-(pyrazine-2-formyl)-L-phenylalanine; (2) carrying out condensation reaction on (R)-1-amino-3-methyl butane-1-boric acid hydrochloride and N-(pyrazine-2-formyl)-L- phenylalanine to obtain bortezomib. The preparation method of bortezomib has the advantages that (R)-1-amino-3-methyl butane-1-boric acid hydrochloride is taken as a reaction raw material, and R)-1-amino-3-methyl butane-1-boric acid hydrochloride is dropwise added to a reaction liquid at a low temperature, so that a side reaction is avoided; meanwhile, a step of removing a protecting group from boric acid is eliminated, so that a reaction period is shortened, production cost is reduced, and product loss in a protection removing step is reduced, and the yield and purity of the bortezomib product are increased.
priorityDate 2013-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103030656-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102206188-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009036281-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103044467-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21801
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID75771
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62652
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11552
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25200171
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416172369
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8078
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454228257
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419515032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2757335
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484729
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7972
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451547506
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7628
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559219
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3382465
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID81531
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158879490
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6425
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1046
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414419746
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6360
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449897534
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487106
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID147922641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10229983
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6212
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID241
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409384644
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558781
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450605620
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419539003
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503663
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10796
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID387447
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448769888
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544915
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527425
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549087
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8895
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448844975
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723939
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419656411
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556475
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410855403
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18662925
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519801
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135399369
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417430547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8058
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523858
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419873614
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419478079
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419511238
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8857

Total number of triples: 100.